Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients
Clinical trial NCT03332329 · UNKNOWN
Trial details
- NCT number
- NCT03332329
- Sponsor
- Qin Ning
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2018-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.